SCHEMBL8568305

SCHEMBL8568305

CC(CN1c2ccccc2Sc2cccc(Cl)c21)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.57
HDAC6 Q9UBN7 2/20 0.57
PTGS1 P23219 3/20 0.49
PTGS2 P35354 2/20 0.49
GFER P55789 2/20 0.48
FNTA P49354 2/20 0.46
FNTB P49356 2/20 0.46
LMNA P02545 3/20 0.45
KMT2A Q03164 2/20 0.45
MEN1 O00255 1/20 0.45
HTR1A P08908 4/20 0.44
DRD3 P35462 4/20 0.44
CYP2D6 P10635 3/20 0.44
CHRM2 P08172 3/20 0.44
ADRA2A P08913 3/20 0.44
CHRM1 P11229 3/20 0.44
DRD1 P21728 3/20 0.44
SLC6A2 P23975 3/20 0.44
SLC6A4 P31645 3/20 0.44
ADRA1A P35348 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8568308 0.74 HDAC6 (0.56) HDAC1HDAC6FNTAFNTBLMNA
SCHEMBL20562284 0.70 PTGS1 (0.60) PTGS1PTGS2GFERFNTAFNTB
SCHEMBL9100585 0.70 HDAC1 (0.51) HDAC1HDAC6LMNAKMT2AMEN1
SCHEMBL9396083 0.67 PTGS1 (1.00) PTGS1PTGS2GFERLMNAKMT2A
SCHEMBL31298153 0.67 PTGS1 (1.00) PTGS1PTGS2GFERLMNAKMT2A
SCHEMBL7932819 0.67 PTGS1 (0.69) PTGS1PTGS2GFERLMNAKMT2A
SCHEMBL9100577 0.67 HDAC1 (0.42) HDAC1HDAC6PTGS1PTGS2CYP2D6
SCHEMBL16316914 0.66 PTGS1 (0.73) PTGS1PTGS2GFERLMNAKMT2A
SCHEMBL5192838 0.66 BCHE (0.50) HDAC1HDAC6HTR2ABCHENOX1
SCHEMBL5435400 0.66 BCHE (0.47) GFERKMT2AHTR1ADRD3CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5861394-A COMPOUNDS AS ANTIISCHEMIC AGENTS, TREATMENT OF STROKES, ANTIHEMORRHEGENIC AGENTS, ANTIDEPRESSANTS OR TREATMENT OF SICKKLE CELL ANEMIA BAYER AKTIENGESELLSCHAFT (DE) 1999-01-19 US disclosed